Article
PSMB5-centered immunotherapy resistance signature predicts prognosis and drives CD8+ T cell exclusion in lung adenocarcinoma
2026-08-18
Abstract excerpt
<h4>Background</h4> Immune checkpoint inhibitors (ICIs) achieve limited response rates in lung adenocarcinoma (LUAD), and the mechanisms underlying immunotherapy resistance remain poorly understood. Robust predictive biomarkers are urgently needed. <h4>Methods</h4> We integrated single-cell transcriptomic data, multi-cohort bulk RNA-seq datasets, and spatial transcriptomics to systematically identify an immunoth...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b40ceeea-57cc-5f88-8c10-83178b7c2e9d
- DOI
- 10.64898/2026.08.16.26360303
